Mouth spray offers relief for cancer patients battling radiation burns
NCT ID NCT07467759
First seen Mar 18, 2026 · Last updated May 16, 2026 · Updated 8 times
Summary
This study tested whether a benzydamine mouth spray (Difflam) can reduce the severity of painful mouth sores caused by high-dose radiation therapy in head and neck cancer patients. 35 adults were randomly assigned to receive either standard mouth care alone or standard care plus the spray for 6 weeks. The spray aims to ease symptoms and prevent sores from getting worse.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RADIATION INDUCED ORAL MUCOSITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pharmacy, Latakia university
Latakia, Syria
Conditions
Explore the condition pages connected to this study.